Veterinary Medicine Information website

EQVALAN DUO ORAL PASTE

Authorised
  • Ivermectin
  • Praziquantel

Product identification

Medicine name:
EQVALAN DUO ORAL PASTE
Active substance:
  • Ivermectin
  • Praziquantel
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ivermectin
    15.50
    milligram(s)
    /
    1.00
    gram(s)
  • Praziquantel
    77.50
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        30
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA51
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Box of 1 sachet of 1 syringe of 7,74 g
  • Box of 50 sachet of 1 syringe of 14,19 g
  • Box of 50 sachets of 1 syringe of 9,68 g
  • Box of 50 sachets of 1 syringe of 7,74 g
  • Box of 1 sachet of 1 syringe of 14,19 g
  • Box of 1 sachet of 1 syringe of 9,68 g

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10256
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0359/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 5/04/2022